|
시장보고서
상품코드
2039006
감기, 기침, 인후통 치료제 시장 : 약제 유형별, 제형별, 유통 채널별, 지역별Cold, Cough, and Sore Throat Remedies Market, By Drug Type, By Formulation, By Distribution Channel, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
감기, 기침, 인후통 치료제 시장은 2026년에 453억 10만 달러로 추계되고 있으며, 2033년까지 565억 20만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 3.5%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 453억 10만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 3.50% | 2033년 시장 규모 예측 : | 565억 20만 달러 |
감기, 기침, 인후통은 다양한 바이러스에 의한 일반적인 감염성 질환으로 항히스타민제, 거담제, 기관지확장제, 충혈제거제 등 다양한 약물로 쉽게 치료할 수 있습니다. 감기와 독감을 유발하는 바이러스 감염의 유병률 증가는 글로벌 감기, 기침, 인후통 치료제 시장의 성장에 유리한 환경을 조성하고 있습니다. 호주 헬스 다이렉트(Australia Health Direct)에 따르면 전 세계에 존재하는 200여 종의 바이러스가 감기를 유발할 수 있으며, 성인은 1년에 2-4회 정도 감기에 걸리기 쉽다고 합니다. 이 정보원은 또한 감기와 독감 증상은 보통 경증에서 중등도이며 자연 치유되는 경향이 있으며, 시판 의약품에 대한 수요가 증가하여 시장 성장을 촉진하고 있다고 지적했습니다.
세계의 감기, 기침, 인후통 치료제 시장 억제요인.
신흥 국가에서는 가정요법 등 대체 치료법이 활용되고 있으며, 이는 시장 성장을 어느 정도 억제하고 있습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 매출기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요 인사이트도 제공합니다.
- 이 연구는 다음과 같은 매개 변수를 기반으로 세계의 감기, 기침 및 인후통 치료제 시장의 주요 기업 개요을 작성했습니다. 기업 개요, 재무 실적, 제품 포트폴리오, 사업 전개 지역, 유통 전략, 주요 발전, 전략 및 미래 계획입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 기술 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 세계의 감기, 기침 및 인후통 치료제 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 시장 분석에 사용되는 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 할 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 범위
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 감기·기침·인후통 치료제 시장 : 약제 유형별, 2021-2033년
제5장 세계의 감기, 기침, 인후통 치료제 시장 : 제형별, 2021-2033년
제6장 세계의 감기·기침·인후통 치료제 시장 : 유통 채널별, 2021-2033년
제7장 세계의 감기·기침·인후통 치료제 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
KSA 26.06.02Cold, Cough, and Sore Throat Remedies Market is estimated to be valued at USD 45,300.1 Mn in 2026 and is expected to reach USD 56,500.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 3.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 45,300.1 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 3.50% | 2033 Value Projection: | USD 56,500.2 Mn |
Cold, cough, and sore throat are common infections occurring due to different viruses and can be easily treated with various medications such as antihistamines, expectorants, bronchodilators, decongestants, and others. Increasing prevalence of viral infections causing cold and flu is creating a favorable environment for growth of global cold, cough, and sore throat remedies market. According to Australian Health Direct, over 200 viruses present worldwide can cause cold and adults are susceptible to these viruses around 2-4 times annually. The same source also suggests that the cold and flu symptoms are usually mild to moderate and self-limiting, which is propelling demand for over-the-counter drugs, in turn fueling growth of the market.
Restraints of the Global Cold, Cough, and Sore Throat Remedies Market
Alternative treatment options such as home remedies, and others are used in emerging economies which restrains growth of the market up to certain extent.
Key features of the study
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
- It profiles leading players in the global cold, cough, and sore throat remedies market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Reckitt Benckiser Group PLC, Johnson & Johnson Services, Inc., GlaxoSmithKline plc., Novartis AG, Bayer AG, AstraZeneca plc., Sun Pharmaceutical Industries Ltd., Pfizer Inc., Prestige Brands Holdings, Inc., and Procter & Gamble Co.
- Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
- The global cold, cough, and sore throat remedies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Market Segmentation
- By Drug Type
- Antihistamines
- Expectorants
- Bronchodilators
- Decongestants
- Antibiotics
- Others
- By Formulation
- Oral Syrups
- Tablets/Pills
- Nasal Drops
- Lozenges
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Supermarkets/Hypermarkets
- e-Commerce/Online Pharmacies
- By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Competitive Landscape
- Reckitt Benckiser Group PLC
- Johnson & Johnson Services, Inc.
- GlaxoSmithKline plc.
- Novartis AG
- Bayer AG
- AstraZeneca plc.
- Sun Pharmaceutical Industries Ltd.
- Pfizer Inc.
- Prestige Brands Holdings, Inc.
- Procter & Gamble Co.
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Formulation
- Market Snippet, By Distribution Channel
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- Regulatory Scenario
4. Global Cold, Cough, and Sore Throat Remedies Market, By Drug Type, 2021 - 2033 (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Antihistamines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Segment Trends
- Expectorants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Segment Trends
- Bronchodilators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Segment Trends
- Decongestants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Segment Trends
- Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Segment Trends
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Segment Trends
5. Global Cold, Cough, and Sore Throat Remedies Market, By Formulation, 2021 - 2033 (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Oral Syrups
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Tablets/Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Nasal Drops
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Lozenges
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
6. Global Cold, Cough, and Sore Throat Remedies Market, By Distribution Channel, 2021 - 2033 (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Drug Stores
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Supermarkets/Hypermarkets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- e-Commerce/Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
7. Global Cold, Cough, and Sore Throat Remedies Market, By Regions, 2021 - 2033 (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profiles
- Reckitt Benckiser Group PLC
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson Services, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GlaxoSmithKline plc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bayer AG
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AstraZeneca plc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Prestige Brands Holdings, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Procter & Gamble Co.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Reckitt Benckiser Group PLC
9. Section
- References
- Research Methodology
- About us and Sales Contact
